$IVOB Could Become the Most Favorable Form of IVF
October 21st, 2009 at 8:20 am Posted by The Dean
On Monday, The Dean told the CollegeStock Community that Nadya Suleman’s (a.k.a. Octomom) doctors was expelled from the American Society of Reproductive Medicine (ASRM) and could possibly never perform IVF treatments again. This decision came after an investigation into Dr. Michael Kamrava’s long history of implanting an average of 4.1 embryos per IVF treatment, which often resulted in multiple births.
The Dean has taught the CollegeStock Community that limiting the number of embryos used in IVF treatments has a number of benefits for the infertile couple, would-be babies, and even governments and healthcare providers. In fact, areas like Ontario are seriously considering covering IVF as part of government healthcare because it could save as much as $500 million a year.
But the CollegeStock Community is already aware that financing and government funding could be positive for IVF treatments like $IVOB’s INVO procedure because it makes infertility treatment more affordable and accessible.
Yesterday, a report discussed a recent study conducted by Yale researchers found that IVF insurance coverage directly supported fewer multiple birth pregnancies because “fewer embryos [were] transferred per cycle.” The article also discusses that the average cost of IVF treatments is $9,500 and only 8 states provide full insurance coverage for these procedures.
Especially with all the negative factors surrounding multiple birth pregnancies resulting from the implantation of too many embryos, it comes as no surprise that the ASRM recently revised its recommendations on the number of embryos that should be transferred during IVF procedures.
The ASRM guideline changes enforce that only one additional embryo should be transferred in patients who prognosis is less optimistic, making 2 the maximum number of embryos to be transferred. Doctors must also advise infertile couples about the risks of pregnancy with several fetuses and keep documented records of the advisement and consultations.
ASRM believes these stricter guidelines will significantly reduce the number of multiple birth pregnancies because a previous reform cut down these numbers by nearly 60%.
The Dean sees these new guidelines as necessary and essential in making sure that mothers and babies are healthier. Furthermore, The Dean believes that ASRM could very well see $IVOB’s INVOcell device and INVO procedure as a favorable form of IVF treatment because it already uses a maximum of 2 embryos.
